Delivery Order SPE2DB20D9354-SPE2DB23FX7Q7

Award Date 5/1/23
Potential Completion Date 5/2/23
Potential Value $17K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Defense Logistics Agency, on behalf of the Department of Defense, awarded a firm fixed price delivery order valued at seventeen thousand two hundred forty-five dollars and forty cents ($17,245.40) to DMS Pharmaceutical Group Inc. The order is for one hundred twenty (120) capsules of XTANDI 40 MG to be delivered to a location in Park Ridge, Illinois by June 23, 2023 in support of the Agency's medical supply needs. No set aside designation or subcontracting details were provided. The...
The Defense Logistics Agency awarded a delivery order to DMS Pharmaceutical Group Inc. valued at seventeen thousand two hundred forty-five dollars and forty cents ($17,245.40) to supply one hundred twenty (120) capsules of XTANDI 40 MG CAPSULE. Performance will take place in Park Ridge, Illinois with completion by May 5, 2023. The firm fixed price contract was awarded on May 4, 2023 without a set-aside designation. As the DLA supports military treatment facilities, this order for the prostate...
The Defense Logistics Agency awarded a firm fixed price delivery order valued at thirty-four thousand four hundred ninety dollars and eighty cents ($34,490.80) to DMS Pharmaceutical Group Inc. to supply one hundred twenty (120) capsules of XTANDI 40 MG for prostate cancer treatment. The place of performance is Park Ridge, Illinois, and the period of performance is one day from June 29, 2023 to June 30, 2023. No set aside designation or subcontractors were identified. The Defense Logistics Agency...
The Defense Logistics Agency awarded a firm fixed price delivery order valued at twenty-five thousand, eight hundred sixty-eight dollars and ten cents ($25,868.10) to DMS Pharmaceutical Group Inc. for the procurement of one hundred twenty (120) capsules of XTANDI 40 MG CAPSULE to be delivered to Park Ridge, Illinois. The order was placed under an unspecified contract vehicle and has a period of performance from September 5, 2023 through September 6, 2023. No set aside designations or...
The Defense Logistics Agency awarded a firm fixed price delivery order valued at forty-three thousand one hundred thirteen dollars and fifty cents ($43,113.50) to DMS Pharmaceutical Group Inc. to supply one hundred twenty (120) capsules of XTANDI 40 MG per capsule. The place of performance will be Park Ridge, Illinois for the period of August 28, 2023 through August 29, 2023. No subcontractors or set aside designations were indicated. The Defense Logistics Agency supports military readiness by...
This delivery order, awarded by the Defense Logistics Agency to DMS Pharmaceutical Group Inc., is for the delivery of 120 capsules of XTANDI 40 MG CAPSULE. The potential value of this firm fixed price order is $12,934.05. Performance will occur in Park Ridge, Illinois, with delivery required by May 30, 2023. No set-aside designation was used for this procurement. As the Defense Logistics Agency is responsible for worldwide logistics support for the U.S. military, this order is likely intended to...
The Defense Logistics Agency awarded a firm fixed price delivery order valued at seventeen thousand two hundred forty-five dollars and forty cents ($17,245.40) to DMS Pharmaceutical Group Incorporated. The order is for one hundred twenty (120) capsules of the pharmaceutical product XTANDI 40 MG to be delivered to a location in Park Ridge, Illinois. No subcontractors or set aside designations were indicated. The Defense Logistics Agency supports America's armed forces by providing supplies in...
The Defense Logistics Agency, a combat logistics support agency within the Department of Defense, awarded a firm fixed price delivery order valued at $17,245.40 to DMS Pharmaceutical Group Inc. The order is for 120 capsules of XTANDI 40 MG CAPSULE to be delivered to a location in Park Ridge, Illinois. XTANDI is used to treat men with prostate cancer. The period of performance for this order is from August 29, 2023 through August 30, 2023. No subcontractors or set aside designations were...
The Defense Logistics Agency awarded a firm fixed price delivery order valued at twelve thousand nine hundred thirty-four dollars and five cents ($12,934.05) to DMS Pharmaceutical Group Inc. to supply one hundred twenty (120) capsules of XTANDI 40 MG for prostate cancer treatment. The place of performance is Park Ridge, Illinois and the period of performance is September 7-8, 2023. No set aside designation or subcontractors are indicated. This order is likely placed against DLA's...
The Defense Logistics Agency Troop Support Medical awarded a firm fixed price delivery order valued at four thousand three hundred eleven dollars and thirty-five cents ($4,311.35) to DMS Pharmaceutical Group Incorporated. The order is for one hundred twenty (120) capsules of the pharmaceutical XTANDI 40 MG to be delivered to a location in Park Ridge, Illinois by July 17, 2023. No set aside designation or subcontractors were indicated. The Defense Logistics Agency supports Department of Defense...
  • SPE2DB20D9354
    Indefinite Delivery Contract
  • SPE2DB20D9354-SPE2DB23FX7Q7
    Delivery Order

The Defense Logistics Agency awarded a firm fixed price delivery order to DMS Pharmaceutical Group Inc. valued at approximately seventeen thousand two hundred forty-five dollars and forty cents ($17,245.40) to supply one hundred twenty (120) capsules of XTANDI 40 MG CAPSULE. Performance will take place in Park Ridge, Illinois and is required to be completed by May 2, 2023. The order was awarded on May 1, 2023 under an existing contract vehicle and no set-aside designation was applied. XTANDI is used to treat prostate cancer and this order will support the Defense Logistics Agency's mission to provide medical supplies and pharmaceuticals to military treatment facilities worldwide.

Generated 1/2/24, 7:44 PM